| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | EH domain binding | 9.18e-06 | 2 | 61 | 2 | GO:1990175 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 7.57e-05 | 143 | 61 | 5 | GO:0017124 | |
| GeneOntologyMolecularFunction | ubiquitin-modified histone reader activity | 1.91e-04 | 7 | 61 | 2 | GO:0061649 | |
| GeneOntologyMolecularFunction | protein domain specific binding | EPN3 EPS15 ZNF106 SYNJ1 GATA1 CNTNAP4 RAPGEF1 TNK2 DNAJC6 ALX4 | 2.93e-04 | 875 | 61 | 10 | GO:0019904 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 3.75e-04 | 46 | 61 | 3 | GO:0030020 | |
| GeneOntologyBiologicalProcess | endocytosis | EPN3 EPS15 AMPH EPS15L1 XKR7 SFTPA2 SYNJ1 RAPGEF1 SFTPA1 TNK2 ULK1 DNAJC6 | 5.43e-06 | 827 | 62 | 12 | GO:0006897 |
| GeneOntologyCellularComponent | clathrin-coated pit | 4.27e-06 | 80 | 63 | 5 | GO:0005905 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 5.63e-06 | 12 | 63 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 5.63e-06 | 12 | 63 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen trimer | 6.84e-06 | 88 | 63 | 5 | GO:0005581 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 7.11e-06 | 237 | 63 | 7 | GO:0030136 | |
| GeneOntologyCellularComponent | coated vesicle | 1.21e-05 | 360 | 63 | 8 | GO:0030135 | |
| GeneOntologyCellularComponent | membrane coat | 1.70e-05 | 106 | 63 | 5 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 1.70e-05 | 106 | 63 | 5 | GO:0048475 | |
| GeneOntologyCellularComponent | clathrin coat | 2.45e-05 | 56 | 63 | 4 | GO:0030118 | |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 3.34e-05 | 21 | 63 | 3 | GO:0030132 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 3.34e-05 | 21 | 63 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 8.89e-05 | 5 | 63 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | EPN3 AATK RGPD8 SYNJ1 PAK2 RAPGEF1 TNK2 CCDC38 VPS53 RYR1 HTT | 9.76e-05 | 934 | 63 | 11 | GO:0048471 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.05e-03 | 530 | 63 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | vesicle coat | 1.09e-03 | 67 | 63 | 3 | GO:0030120 | |
| GeneOntologyCellularComponent | presynaptic endocytic zone | 1.33e-03 | 18 | 63 | 2 | GO:0098833 | |
| GeneOntologyCellularComponent | lamellar body | 1.81e-03 | 21 | 63 | 2 | GO:0042599 | |
| GeneOntologyCellularComponent | vesicle membrane | EPN3 EPS15 AMPH COPA SYNJ1 DISP3 RAPGEF1 TNK2 ULK1 VPS53 HTT | 1.86e-03 | 1325 | 63 | 11 | GO:0012506 |
| GeneOntologyCellularComponent | inclusion body | 2.54e-03 | 90 | 63 | 3 | GO:0016234 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 3.04e-03 | 817 | 63 | 8 | GO:0098978 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.50e-03 | 656 | 63 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 3.52e-03 | 101 | 63 | 3 | GO:0045334 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.56e-03 | 658 | 63 | 7 | GO:0030312 | |
| HumanPheno | Abnormal cellular composition of bronchoalveolar fluid | 9.45e-06 | 10 | 23 | 3 | HP:0032974 | |
| HumanPheno | Short stepped shuffling gait | 5.25e-05 | 17 | 23 | 3 | HP:0007311 | |
| HumanPheno | Abnormal bronchoalveolar lavage fluid morphology | 6.28e-05 | 18 | 23 | 3 | HP:0032973 | |
| HumanPheno | Exostoses | 1.01e-04 | 21 | 23 | 3 | HP:0100777 | |
| HumanPheno | short, dumbbell appearance of long bones | 1.16e-04 | 4 | 23 | 2 | HP:0005061 | |
| HumanPheno | Dumbbell-shaped femur | 1.16e-04 | 4 | 23 | 2 | HP:0006375 | |
| HumanPheno | Vitreoretinopathy | 1.17e-04 | 22 | 23 | 3 | HP:0007773 | |
| HumanPheno | Crackles | 1.73e-04 | 25 | 23 | 3 | HP:0030830 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.93e-04 | 5 | 23 | 2 | HP:0007964 | |
| HumanPheno | Decreased DLCO | 1.95e-04 | 26 | 23 | 3 | HP:0045051 | |
| HumanPheno | Abnormal DLCO | 1.95e-04 | 26 | 23 | 3 | HP:0045049 | |
| HumanPheno | Elevated bronchoalveolar lavage fluid neutrophil proportion | 2.89e-04 | 6 | 23 | 2 | HP:0032977 | |
| HumanPheno | Slowed slurred speech | 2.89e-04 | 6 | 23 | 2 | HP:0007164 | |
| MousePheno | increased susceptibility to malignant hyperthermia | 1.46e-05 | 2 | 54 | 2 | MP:0020214 | |
| Domain | Fib_collagen_C | 5.37e-06 | 11 | 61 | 3 | IPR000885 | |
| Domain | COLFI | 5.37e-06 | 11 | 61 | 3 | PF01410 | |
| Domain | NC1_FIB | 5.37e-06 | 11 | 61 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 5.37e-06 | 11 | 61 | 3 | PD002078 | |
| Domain | COLFI | 5.37e-06 | 11 | 61 | 3 | SM00038 | |
| Domain | Collagen | 8.44e-06 | 85 | 61 | 5 | IPR008160 | |
| Domain | Collagen | 8.44e-06 | 85 | 61 | 5 | PF01391 | |
| Domain | Laminin_G_2 | 8.62e-06 | 40 | 61 | 4 | PF02210 | |
| Domain | LamG | 1.27e-05 | 44 | 61 | 4 | SM00282 | |
| Domain | BAT2_N | 3.14e-05 | 3 | 61 | 2 | PF07001 | |
| Domain | BAT2_N | 3.14e-05 | 3 | 61 | 2 | IPR009738 | |
| Domain | PRRC2 | 3.14e-05 | 3 | 61 | 2 | IPR033184 | |
| Domain | Laminin_G | 3.83e-05 | 58 | 61 | 4 | IPR001791 | |
| Domain | ConA-like_dom | 7.87e-05 | 219 | 61 | 6 | IPR013320 | |
| Domain | - | 2.63e-04 | 95 | 61 | 4 | 2.60.120.200 | |
| Domain | EF-hand_4 | 4.64e-04 | 10 | 61 | 2 | PF12763 | |
| Domain | Grip | 5.66e-04 | 11 | 61 | 2 | SM00755 | |
| Domain | EH | 5.66e-04 | 11 | 61 | 2 | PS50031 | |
| Domain | GRIP | 5.66e-04 | 11 | 61 | 2 | PF01465 | |
| Domain | EH | 5.66e-04 | 11 | 61 | 2 | SM00027 | |
| Domain | EH_dom | 5.66e-04 | 11 | 61 | 2 | IPR000261 | |
| Domain | Ran_BP1 | 6.78e-04 | 12 | 61 | 2 | PF00638 | |
| Domain | GRIP_dom | 6.78e-04 | 12 | 61 | 2 | IPR000237 | |
| Domain | GRIP | 6.78e-04 | 12 | 61 | 2 | PS50913 | |
| Domain | RANBD1 | 6.78e-04 | 12 | 61 | 2 | PS50196 | |
| Domain | SH3 | 6.94e-04 | 216 | 61 | 5 | SM00326 | |
| Domain | SH3 | 6.94e-04 | 216 | 61 | 5 | PS50002 | |
| Domain | SH3_domain | 7.54e-04 | 220 | 61 | 5 | IPR001452 | |
| Domain | RanBD | 8.00e-04 | 13 | 61 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 8.00e-04 | 13 | 61 | 2 | IPR000156 | |
| Domain | CRIB | 1.92e-03 | 20 | 61 | 2 | PS50108 | |
| Domain | SH3_1 | 2.03e-03 | 164 | 61 | 4 | PF00018 | |
| Domain | UIM | 2.12e-03 | 21 | 61 | 2 | SM00726 | |
| Domain | CRIB_dom | 2.12e-03 | 21 | 61 | 2 | IPR000095 | |
| Domain | SH3_9 | 2.12e-03 | 78 | 61 | 3 | PF14604 | |
| Domain | TSPN | 2.54e-03 | 23 | 61 | 2 | SM00210 | |
| Domain | UIM | 2.77e-03 | 24 | 61 | 2 | PS50330 | |
| Domain | SH3_2 | 2.80e-03 | 86 | 61 | 3 | IPR011511 | |
| Domain | SH3_2 | 2.80e-03 | 86 | 61 | 3 | PF07653 | |
| Domain | UIM_dom | 3.00e-03 | 25 | 61 | 2 | IPR003903 | |
| Domain | - | 4.30e-03 | 30 | 61 | 2 | 1.20.1270.60 | |
| Domain | AH/BAR-dom | 4.30e-03 | 30 | 61 | 2 | IPR027267 | |
| Domain | LAM_G_DOMAIN | 6.84e-03 | 38 | 61 | 2 | PS50025 | |
| Domain | EF_hand_dom | 6.96e-03 | 232 | 61 | 4 | IPR002048 | |
| Domain | C-type_lectin_CS | 8.69e-03 | 43 | 61 | 2 | IPR018378 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.74e-06 | 67 | 43 | 5 | MM15345 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.94e-06 | 30 | 43 | 4 | MM15517 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.96e-06 | 79 | 43 | 5 | M27643 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 7.00e-06 | 41 | 43 | 4 | M27778 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 9.40e-06 | 14 | 43 | 3 | MM15011 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 1.44e-05 | 16 | 43 | 3 | M925 | |
| Pathway | WP_FOCAL_ADHESION | 2.04e-05 | 187 | 43 | 6 | MM15913 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.48e-05 | 19 | 43 | 3 | MM15512 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.26e-05 | 418 | 43 | 8 | MM15587 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 6.84e-05 | 142 | 43 | 5 | MM15499 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 7.55e-05 | 145 | 43 | 5 | M27753 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | 9.67e-05 | 630 | 43 | 9 | M11480 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.01e-04 | 30 | 43 | 3 | M27772 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.23e-04 | 32 | 43 | 3 | MM14924 | |
| Pathway | WP_EGFEGFR_SIGNALING | 1.27e-04 | 162 | 43 | 5 | M39334 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.76e-04 | 532 | 43 | 8 | M27870 | |
| Pathway | REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5 | 2.52e-04 | 8 | 43 | 2 | M27575 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 2.55e-04 | 188 | 43 | 5 | MM15828 | |
| Pathway | PID_ERBB1_INTERNALIZATION_PATHWAY | 2.60e-04 | 41 | 43 | 3 | M214 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.60e-04 | 41 | 43 | 3 | MM15538 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 2.79e-04 | 725 | 43 | 9 | M27507 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.88e-04 | 302 | 43 | 6 | M39719 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.21e-04 | 44 | 43 | 3 | M27812 | |
| Pathway | WP_FOCAL_ADHESION | 3.32e-04 | 199 | 43 | 5 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.32e-04 | 199 | 43 | 5 | M7253 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 3.66e-04 | 46 | 43 | 3 | M48105 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM | 4.03e-04 | 10 | 43 | 2 | M27573 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.33e-04 | 326 | 43 | 6 | MM15917 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.69e-04 | 50 | 43 | 3 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.57e-04 | 53 | 43 | 3 | MM14566 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 6.44e-04 | 645 | 43 | 8 | MM15232 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.90e-04 | 57 | 43 | 3 | MM14713 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION | 6.94e-04 | 13 | 43 | 2 | M47674 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.26e-04 | 58 | 43 | 3 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.63e-04 | 59 | 43 | 3 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 8.41e-04 | 61 | 43 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 8.41e-04 | 61 | 43 | 3 | MM14637 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 9.31e-04 | 15 | 43 | 2 | MM1387 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 9.68e-04 | 64 | 43 | 3 | M26953 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 9.80e-04 | 381 | 43 | 6 | M48063 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.06e-03 | 16 | 43 | 2 | M16498 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.11e-03 | 67 | 43 | 3 | M26999 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 1.20e-03 | 17 | 43 | 2 | M2482 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.20e-03 | 17 | 43 | 2 | M5940 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 1.35e-03 | 18 | 43 | 2 | MM15024 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.47e-03 | 74 | 43 | 3 | M160 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 1.50e-03 | 19 | 43 | 2 | M27310 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.59e-03 | 76 | 43 | 3 | MM14573 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.67e-03 | 20 | 43 | 2 | MM15061 | |
| Pathway | PID_MET_PATHWAY | 1.78e-03 | 79 | 43 | 3 | M48 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 2.02e-03 | 22 | 43 | 2 | M27571 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 2.02e-03 | 22 | 43 | 2 | MM15284 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.12e-03 | 84 | 43 | 3 | M7098 | |
| Pathway | KEGG_ENDOCYTOSIS | 2.20e-03 | 181 | 43 | 4 | M1519 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 2.21e-03 | 23 | 43 | 2 | MM15279 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.58e-03 | 90 | 43 | 3 | M631 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 2.83e-03 | 93 | 43 | 3 | MM15609 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 2.92e-03 | 94 | 43 | 3 | M41818 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 3.04e-03 | 27 | 43 | 2 | MM14809 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 3.10e-03 | 96 | 43 | 3 | MM14592 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 3.68e-03 | 102 | 43 | 3 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 3.68e-03 | 102 | 43 | 3 | MM15830 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 3.74e-03 | 30 | 43 | 2 | M27566 | |
| Pathway | WP_AUTOPHAGY | 3.74e-03 | 30 | 43 | 2 | M39904 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 4.00e-03 | 31 | 43 | 2 | MM14705 | |
| Pathway | REACTOME_EGFR_DOWNREGULATION | 4.00e-03 | 31 | 43 | 2 | M16597 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.02e-03 | 114 | 43 | 3 | MM14571 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 5.07e-03 | 35 | 43 | 2 | MM15114 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPN3 HIVEP3 EPS15L1 MSRB1 AATK SYNJ1 PIK3C2B CHD5 RAPGEF1 TNK2 ULK1 ADGRA2 CIC RYR1 PRRC2B ANO8 HTT | 7.76e-12 | 1105 | 63 | 17 | 35748872 |
| Pubmed | The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R. | 5.65e-08 | 5 | 63 | 3 | 7797522 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 RGPD8 SYNJ1 PIK3C2B PRRC2C ZNF629 SORBS1 CIC TP53BP1 PRRC2B | 1.01e-07 | 588 | 63 | 10 | 38580884 |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 3.15e-07 | 8 | 63 | 3 | 20059976 | |
| Pubmed | Accessory protein recruitment motifs in clathrin-mediated endocytosis. | 4.72e-07 | 9 | 63 | 3 | 12057195 | |
| Pubmed | 6.74e-07 | 10 | 63 | 3 | 24591256 | ||
| Pubmed | 9.25e-07 | 11 | 63 | 3 | 12456676 | ||
| Pubmed | EPS15 EPS15L1 RGPD8 SYNJ1 PRRC2C PAK2 TRIM21 SORBS1 DNAJC6 TP53BP1 PRRC2B | 1.15e-06 | 963 | 63 | 11 | 28671696 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.29e-06 | 475 | 63 | 8 | 31040226 | |
| Pubmed | 2.71e-06 | 486 | 63 | 8 | 20936779 | ||
| Pubmed | Major Effect of Oxidative Stress on the Male, but Not Female, SP-A1 Type II Cell miRNome. | 3.23e-06 | 2 | 63 | 2 | 31354704 | |
| Pubmed | Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4. | 3.23e-06 | 2 | 63 | 2 | 35444643 | |
| Pubmed | Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. | 3.23e-06 | 2 | 63 | 2 | 10749762 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 17593964 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 2610270 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 9922219 | ||
| Pubmed | Maternal surfactant protein A influences the immunoprotective properties of milk in a murine model. | 3.23e-06 | 2 | 63 | 2 | 24858142 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 11867335 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 19228388 | ||
| Pubmed | SP-A preserves airway homeostasis during Mycoplasma pneumoniae infection in mice. | 3.23e-06 | 2 | 63 | 2 | 19494306 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24793167 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24954098 | ||
| Pubmed | Characterization of a second human pulmonary surfactant-associated protein SP-A gene. | 3.23e-06 | 2 | 63 | 2 | 1372511 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 21257967 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 21205009 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 11237662 | ||
| Pubmed | Surfactant protein A modulates neuroinflammation in adult mice upon pulmonary infection. | 3.23e-06 | 2 | 63 | 2 | 38964703 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 34917085 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22219327 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15890661 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15385504 | ||
| Pubmed | A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation. | 3.23e-06 | 2 | 63 | 2 | 23475791 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 23038062 | ||
| Pubmed | Surfactant protein A binds flagellin enhancing phagocytosis and IL-1β production. | 3.23e-06 | 2 | 63 | 2 | 24312669 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24984162 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 17580966 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 3755136 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 29394894 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22384248 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 19155504 | ||
| Pubmed | Surfactant Protein A can Affect the Surface Tension of the Eustachian Tube and Macrophage Migration. | 3.23e-06 | 2 | 63 | 2 | 36102297 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 17307210 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 36792618 | ||
| Pubmed | Surfactant protein A modulates induction of regulatory T cells via TGF-β. | 3.23e-06 | 2 | 63 | 2 | 22474025 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 11504713 | ||
| Pubmed | Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice. | 3.23e-06 | 2 | 63 | 2 | 38553537 | |
| Pubmed | Surfactant protein A reduces TLR4 and inflammatory cytokine mRNA levels in neonatal mouse ileum. | 3.23e-06 | 2 | 63 | 2 | 33510368 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 19392648 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20448439 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20048345 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 32855221 | ||
| Pubmed | Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. | 3.23e-06 | 2 | 63 | 2 | 11342662 | |
| Pubmed | Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. | 3.23e-06 | 2 | 63 | 2 | 9126996 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24080545 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 2050021 | ||
| Pubmed | Murine pulmonary surfactant SP-A gene: cloning, sequence, and transcriptional activity. | 3.23e-06 | 2 | 63 | 2 | 1443158 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 27835691 | ||
| Pubmed | Genetic Variation in Surfactant Protein-A2 Delays Resolution of Eosinophilia in Asthma. | 3.23e-06 | 2 | 63 | 2 | 31350355 | |
| Pubmed | Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2. | 3.23e-06 | 2 | 63 | 2 | 23069847 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 19055785 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 34484180 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15857803 | ||
| Pubmed | Surfactant protein-A reduces translocation of mediators from the lung into the circulation. | 3.23e-06 | 2 | 63 | 2 | 20715984 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 19335775 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 12922979 | ||
| Pubmed | Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms. | 3.23e-06 | 2 | 63 | 2 | 18159253 | |
| Pubmed | Differences in the alveolar macrophage toponome in humanized SP-A1 and SP-A2 transgenic mice. | 3.23e-06 | 2 | 63 | 2 | 33141765 | |
| Pubmed | Regulatory roles of SP-A and exosomes in pneumonia-induced acute lung and kidney injuries. | 3.23e-06 | 2 | 63 | 2 | 37256132 | |
| Pubmed | Surfactant protein a attenuates generalized and localized neuroinflammation in neonatal mice. | 3.23e-06 | 2 | 63 | 2 | 36871846 | |
| Pubmed | Innate immunity of surfactant protein A in experimental otitis media. | 3.23e-06 | 2 | 63 | 2 | 31378117 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 33267655 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 11237812 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 10781424 | ||
| Pubmed | SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues. | 3.23e-06 | 2 | 63 | 2 | 12676766 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 27916681 | ||
| Pubmed | Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. | 3.23e-06 | 2 | 63 | 2 | 12959932 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15044702 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 1986781 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 12740217 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 18083768 | ||
| Pubmed | Structural characterisation of human proteinosis surfactant protein A. | 3.23e-06 | 2 | 63 | 2 | 11087951 | |
| Pubmed | Surfactant protein-A inhibits Aspergillus fumigatus-induced allergic T-cell responses. | 3.23e-06 | 2 | 63 | 2 | 16120217 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 29202868 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 35322074 | ||
| Pubmed | Surfactant protein A regulates surfactant phospholipid clearance after LPS-induced injury in vivo. | 3.23e-06 | 2 | 63 | 2 | 12060563 | |
| Pubmed | Surfactant Protein-A Protects against IL-13-Induced Inflammation in Asthma. | 3.23e-06 | 2 | 63 | 2 | 32245819 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 9700084 | ||
| Pubmed | Novel role for surfactant protein A in gastrointestinal graft-versus-host disease. | 3.23e-06 | 2 | 63 | 2 | 22508928 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20963503 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20693318 | ||
| Pubmed | Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. | 3.23e-06 | 2 | 63 | 2 | 11839553 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 25605768 | ||
| Pubmed | Surfactant protein A decreases lung injury and mortality after murine marrow transplantation. | 3.23e-06 | 2 | 63 | 2 | 12204891 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 12959946 | ||
| Pubmed | Surfactant protein-A enhances ureaplasmacidal activity in vitro. | 3.23e-06 | 2 | 63 | 2 | 20197455 | |
| Pubmed | SHARPIN negatively associates with TRAF2-mediated NFκB activation. | 5.38e-06 | 19 | 63 | 3 | 21829440 | |
| Pubmed | 6.62e-06 | 549 | 63 | 8 | 38280479 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 12015304 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 9428629 | ||
| Pubmed | Surfactant proteins SP-A and SP-D: structure, function and receptors. | 9.68e-06 | 3 | 63 | 2 | 16213021 | |
| Interaction | TOP3B interactions | EPN3 HIVEP3 EPS15L1 MSRB1 AATK SYNJ1 PIK3C2B CHD5 RAPGEF1 TNK2 ULK1 ADGRA2 CIC RYR1 TP53BP1 PRRC2B ANO8 HTT | 2.58e-07 | 1470 | 62 | 18 | int:TOP3B |
| Interaction | ITSN1 interactions | 1.24e-06 | 259 | 62 | 8 | int:ITSN1 | |
| Interaction | AMPH interactions | 2.79e-06 | 72 | 62 | 5 | int:AMPH | |
| Interaction | EPS15 interactions | 4.96e-06 | 220 | 62 | 7 | int:EPS15 | |
| Interaction | SGIP1 interactions | 1.68e-05 | 50 | 62 | 4 | int:SGIP1 | |
| Interaction | SYNJ1 interactions | 1.87e-05 | 106 | 62 | 5 | int:SYNJ1 | |
| Interaction | AP2A2 interactions | 3.34e-05 | 199 | 62 | 6 | int:AP2A2 | |
| Interaction | AP2A1 interactions | 3.61e-05 | 299 | 62 | 7 | int:AP2A1 | |
| Interaction | BIN1 interactions | 4.80e-05 | 129 | 62 | 5 | int:BIN1 | |
| Interaction | AP2M1 interactions | 4.96e-05 | 430 | 62 | 8 | int:AP2M1 | |
| Interaction | AP1B1 interactions | 8.80e-05 | 237 | 62 | 6 | int:AP1B1 | |
| Interaction | YWHAG interactions | ZNF106 SYNJ1 PIK3C2B PRRC2C ZNF629 PAK2 NHS TNK2 TRIM21 SORBS1 ULK1 CIC HTT | 8.91e-05 | 1248 | 62 | 13 | int:YWHAG |
| Interaction | ITSN2 interactions | 8.93e-05 | 147 | 62 | 5 | int:ITSN2 | |
| Interaction | MAP1LC3A interactions | 9.65e-05 | 241 | 62 | 6 | int:MAP1LC3A | |
| Interaction | AP2B1 interactions | 1.44e-04 | 373 | 62 | 7 | int:AP2B1 | |
| Interaction | NCK2 interactions | 1.52e-04 | 262 | 62 | 6 | int:NCK2 | |
| Interaction | REPS2 interactions | 1.55e-04 | 34 | 62 | 3 | int:REPS2 | |
| Interaction | SH3GL2 interactions | 1.56e-04 | 88 | 62 | 4 | int:SH3GL2 | |
| Interaction | GRB2 interactions | EPS15 ZNF106 EPS15L1 ASAP2 SYNJ1 PIK3C2B PAK2 RAPGEF1 TNK2 HTT | 1.61e-04 | 806 | 62 | 10 | int:GRB2 |
| Interaction | INSYN1 interactions | 1.72e-04 | 169 | 62 | 5 | int:INSYN1 | |
| Interaction | TSKS interactions | 2.53e-04 | 40 | 62 | 3 | int:TSKS | |
| Interaction | SFTPA1 interactions | 2.58e-04 | 8 | 62 | 2 | int:SFTPA1 | |
| Interaction | AJM1 interactions | 2.58e-04 | 8 | 62 | 2 | int:AJM1 | |
| Interaction | CLTB interactions | 2.62e-04 | 185 | 62 | 5 | int:CLTB | |
| Cytoband | 2q13 | 1.16e-04 | 68 | 63 | 3 | 2q13 | |
| GeneFamily | Collagens | 1.22e-04 | 46 | 38 | 3 | 490 | |
| GeneFamily | Collectins | 1.92e-04 | 10 | 38 | 2 | 491 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.35e-03 | 41 | 38 | 2 | 1298 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SEMA3A HIVEP3 AATK SYNJ1 CHD5 CNTNAP4 TNK2 SORBS1 AMER3 DNAJC6 VPS53 PRRC2B ANO8 | 1.84e-06 | 1106 | 63 | 13 | M39071 |
| Coexpression | NABA_CORE_MATRISOME | 4.34e-06 | 275 | 63 | 7 | M5884 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN | 1.55e-05 | 130 | 63 | 5 | M6087 | |
| Coexpression | NABA_CORE_MATRISOME | 4.70e-05 | 270 | 63 | 6 | MM17057 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED | 5.66e-05 | 5 | 63 | 2 | M47996 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.12e-06 | 194 | 63 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-05 | 125 | 63 | 4 | 43aa4b77dccf0ea2979218826af16034f2017c3a | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.77e-05 | 141 | 63 | 4 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.46e-05 | 146 | 63 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-05 | 149 | 63 | 4 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.91e-05 | 149 | 63 | 4 | 649eb3441fa859591ea85f1ed5fcf08af272a32b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-05 | 149 | 63 | 4 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 7.42e-05 | 158 | 63 | 4 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 164 | 63 | 4 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-5|TCGA-Bladder / Sample_Type by Project: Shred V9 | 9.63e-05 | 169 | 63 | 4 | 9c4e83fe8225d16173a103bf5a57b17d623be923 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 171 | 63 | 4 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 172 | 63 | 4 | 51bea97564a33f0060c546c9be4bf8bf8f1660f6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 172 | 63 | 4 | be4dd4ba8d7a651677c797c25fd75f14e627415a | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 173 | 63 | 4 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 175 | 63 | 4 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | wk_20-22-Epithelial-PNS-Late_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 176 | 63 | 4 | 81924471d8a8c5bd8eedf294c007e25b6cd3e417 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 176 | 63 | 4 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 176 | 63 | 4 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 176 | 63 | 4 | da5933eb253f13e70296a50a2bb00ad5c19a2d99 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 176 | 63 | 4 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 179 | 63 | 4 | 3d6bb3cfe89d60f2f00aead9341f9967e5313763 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 179 | 63 | 4 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 180 | 63 | 4 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 180 | 63 | 4 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 182 | 63 | 4 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 182 | 63 | 4 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 182 | 63 | 4 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 182 | 63 | 4 | eb4be1c02b8b033d025e57b8b4cdbfaec4698054 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 183 | 63 | 4 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 183 | 63 | 4 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 185 | 63 | 4 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | 18-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 1.36e-04 | 185 | 63 | 4 | d2a266724f3f70f746a78034f308d98f8b7a66e3 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.39e-04 | 186 | 63 | 4 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 187 | 63 | 4 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 187 | 63 | 4 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.42e-04 | 187 | 63 | 4 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 188 | 63 | 4 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 188 | 63 | 4 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 188 | 63 | 4 | 340f0e3e65c7a00d82d26621ff37107458bebc41 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 188 | 63 | 4 | 9d384c0934f1461bc37b1f83e0877d7bee2116ee | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.45e-04 | 188 | 63 | 4 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-04 | 188 | 63 | 4 | c9270517e6940e9793586f67f02431210552f278 | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 1.48e-04 | 189 | 63 | 4 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 1.48e-04 | 189 | 63 | 4 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.51e-04 | 190 | 63 | 4 | a8d92645950715d2621bf0064b1b2bb4eb400cb3 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 191 | 63 | 4 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 192 | 63 | 4 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 193 | 63 | 4 | df4afb4848eb9d7d8d39e5c612919663cbbb2514 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 193 | 63 | 4 | ab36d684bde8fe77d11a5188425135328052c58b | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.64e-04 | 194 | 63 | 4 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | 15-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 1.67e-04 | 195 | 63 | 4 | 56356a9aeb67b50a74425be2cd9c50d31416c1b3 | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 195 | 63 | 4 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-04 | 199 | 63 | 4 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.84e-04 | 200 | 63 | 4 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| Drug | o-nitrophenyl beta-D-fucopyranoside | 1.92e-06 | 74 | 63 | 5 | CID000004597 | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.61e-05 | 194 | 63 | 6 | 4260_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.70e-05 | 196 | 63 | 6 | 3604_UP | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; HL60; HG-U133A | 1.70e-05 | 196 | 63 | 6 | 1379_UP | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A | 1.75e-05 | 197 | 63 | 6 | 4545_UP | |
| Disease | Megaepiphyseal dwarfism | 3.93e-06 | 2 | 59 | 2 | C1855310 | |
| Disease | Otospondylomegaepiphyseal dysplasia | 3.93e-06 | 2 | 59 | 2 | C4520892 | |
| Disease | Stickler syndrome, type 3 | 3.93e-06 | 2 | 59 | 2 | C1861481 | |
| Disease | Atypical juvenile parkinsonism | 1.18e-05 | 3 | 59 | 2 | C4510873 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 3.28e-05 | 31 | 59 | 3 | C1335167 | |
| Disease | Stickler syndrome | 3.92e-05 | 5 | 59 | 2 | cv:C0265253 | |
| Disease | level of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum | 3.92e-05 | 5 | 59 | 2 | OBA_2042200 | |
| Disease | Polyarthritis | 3.92e-05 | 5 | 59 | 2 | C0162323 | |
| Disease | level of prosaposin in blood serum | 3.92e-05 | 5 | 59 | 2 | OBA_2044552 | |
| Disease | newborn respiratory distress syndrome (biomarker_via_orthology) | 5.87e-05 | 6 | 59 | 2 | DOID:12716 (biomarker_via_orthology) | |
| Disease | Cartilage Diseases | 5.87e-05 | 6 | 59 | 2 | C0007302 | |
| Disease | Chondromalacia | 5.87e-05 | 6 | 59 | 2 | C0085700 | |
| Disease | Arthritis | 5.87e-05 | 6 | 59 | 2 | C0003864 | |
| Disease | newborn respiratory distress syndrome (is_implicated_in) | 8.20e-05 | 7 | 59 | 2 | DOID:12716 (is_implicated_in) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 1.09e-04 | 8 | 59 | 2 | EFO_0801768 | |
| Disease | Sensory hearing loss | 2.14e-04 | 11 | 59 | 2 | C1691779 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.56e-04 | 12 | 59 | 2 | EFO_0801493 | |
| Disease | cleft palate (is_implicated_in) | 2.56e-04 | 12 | 59 | 2 | DOID:674 (is_implicated_in) | |
| Disease | granulins measurement | 2.56e-04 | 12 | 59 | 2 | EFO_0008141 | |
| Disease | xanthine measurement | 3.02e-04 | 13 | 59 | 2 | EFO_0010548 | |
| Disease | Hamman-Rich syndrome | 3.52e-04 | 14 | 59 | 2 | C0085786 | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 3.52e-04 | 14 | 59 | 2 | DOID:874 (biomarker_via_orthology) | |
| Disease | peak expiratory flow | 4.74e-04 | 498 | 59 | 6 | EFO_0009718 | |
| Disease | Parkinson's disease (is_implicated_in) | 4.81e-04 | 76 | 59 | 3 | DOID:14330 (is_implicated_in) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 6.58e-04 | 19 | 59 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 7.30e-04 | 20 | 59 | 2 | C4721952 | |
| Disease | Idiopathic Pulmonary Fibrosis | 8.05e-04 | 21 | 59 | 2 | C1800706 | |
| Disease | Disorder of eye | 8.65e-04 | 212 | 59 | 4 | C0015397 | |
| Disease | Sensorineural Hearing Loss (disorder) | 9.68e-04 | 23 | 59 | 2 | C0018784 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 1.05e-03 | 24 | 59 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | neuroimaging measurement | 1.25e-03 | 1069 | 59 | 8 | EFO_0004346 | |
| Disease | thrombocytopenia (is_implicated_in) | 1.34e-03 | 27 | 59 | 2 | DOID:1588 (is_implicated_in) | |
| Disease | unipolar depression, bipolar disorder, seasonality measurement | 1.65e-03 | 30 | 59 | 2 | EFO_0003761, EFO_0006876, MONDO_0004985 | |
| Disease | lupus nephritis | 1.99e-03 | 33 | 59 | 2 | EFO_0005761 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSPFRAFPGGDKFGT | 31 | Q9H161 | |
| SDPGGRRSKAFLPPG | 191 | Q8N944 | |
| FGDPFSGKDPFVPSS | 831 | Q9UBC2 | |
| RKVDSPFGPGSPSKG | 61 | Q9UGJ0 | |
| PFGPGSPSKGFFSRG | 66 | Q9UGJ0 | |
| SPDGPTKGFFFVPSE | 961 | Q9P2K9 | |
| PPPFDYGSGDEDGKS | 551 | Q8TDI0 | |
| PFGPNKTESPGDFAP | 341 | Q68CJ9 | |
| GSPVFGEGPPSLKSS | 1106 | Q96PE1 | |
| PGGASTFDPFAKPPE | 416 | Q9H201 | |
| EPQGFRGSFAASPGP | 286 | C9J069 | |
| SFGGIPAPGKSVSFP | 311 | Q9C0A0 | |
| STFRKTSPAPGGPAG | 96 | Q07912 | |
| FDPFKPEVTPAGSAG | 356 | P49418 | |
| AGKLFPFGGTRAEPG | 1051 | Q9HCE9 | |
| SAFAGLGPREKGPDP | 1221 | P02458 | |
| PVSADGFKFGISEPG | 916 | Q99666 | |
| PVSADGFKFGISEPG | 916 | O14715 | |
| PTKKSPGPDGFTAEF | 466 | O00370 | |
| PLPKSGSVFIGGFPD | 2006 | Q5T1H1 | |
| IDGDPGRKGAFPVSF | 986 | O43150 | |
| PRSFKGDRGPGSPTT | 1061 | Q8ND23 | |
| PFLKPTGAGQRFGTP | 81 | O15117 | |
| PTRQLFPGGFPKDFS | 71 | P13942 | |
| DSGDGSFLKPSQPFP | 576 | Q8N3J3 | |
| SPPGDKFSPRYEFGS | 796 | O00750 | |
| SFTPPEKDGFPSGTP | 141 | Q13177 | |
| GSGLSSRFEEPKGPP | 301 | Q8NA61 | |
| STPESGVFFPSGPEG | 26 | P15976 | |
| SPKPGGDFGTAFPEI | 2421 | P42858 | |
| GAEDGFFVPPTKGTS | 901 | P53621 | |
| GEGATFDPFGAPSKP | 576 | O75061 | |
| RSGRSFEKFGPGPAP | 81 | Q502W7 | |
| GGGPSDPSEFGTEFR | 76 | Q9NU39 | |
| PFGGDPFKGSDPFAS | 641 | P42566 | |
| CFFSHGPKGSEPPGR | 66 | Q9Y5M1 | |
| AKPSESRHPGPGSFG | 256 | Q15768 | |
| SLDSFSGKPRGSGPP | 416 | P21817 | |
| PFQFAGGSFKGPPVS | 446 | P25940 | |
| GPKPGQSRFUIFSSS | 86 | Q9NZV6 | |
| APTRKEFGGIGAPPS | 1136 | O43426 | |
| FPGAKESPPTFLRGS | 1256 | Q6ZMQ8 | |
| FPTAFFSGPLSPGGS | 1036 | Q6T4R5 | |
| GGPERVTFHSTPGPK | 116 | Q8WTR8 | |
| SGPPSKSGKRGPFDD | 1576 | Q9Y520 | |
| PRPGTCPSKTFGGFD | 376 | Q14563 | |
| EGPSPGDFRYSDGTP | 191 | Q8IWL1 | |
| EGPSPGDFRYSDGTP | 191 | Q8IWL2 | |
| SGQGEKPAAPFPRGE | 136 | Q9GZN2 | |
| PGAGGPATPSKATRF | 576 | Q96RK0 | |
| SAAPTGGGRFSEPDP | 341 | Q9H4F8 | |
| GAFRTKEGSPEPGPQ | 146 | Q5GH72 | |
| ESLGESGSPFLGPPF | 416 | Q13905 | |
| TQRGSFAFADKGPPP | 176 | Q5TH74 | |
| RPGKPLGSAFPGSEA | 1176 | Q9BX66 | |
| TGFQPRTPKPGSGSE | 771 | Q5T1R4 | |
| FGVSPKDSDFSLPPG | 1786 | Q5JSZ5 | |
| PADFALPSSRGGPGK | 1346 | Q12888 | |
| PLRPFFSPGFNDGGK | 441 | P19474 | |
| EAFPSQGTKRPGGPS | 221 | Q5VIR6 | |
| GAEASTFGGFPESPP | 631 | A7E2V4 | |
| EGAGPSPFLSGKPFK | 701 | Q9UEG4 | |
| PPRGGINKDSTSPGF | 256 | Q9Y334 | |
| GPSEGFTSDKFPSEG | 296 | Q9H2Y7 | |
| PGEDPKGPFGRSFST | 681 | O75385 |